GGrantIndex
← Leaderboards

F. Patrick Ross

Barnes-Jewish Hospital

$4,287,010
Attributed
$4,287,010
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $796.3K · FY200509
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$4,287,010 · 6

By mechanism

R01$3,907,353 · 2
R21$363,651 · 1
P41$16,006 · 3

Top collaborators

No co-investigators on record.

Most similar at Barnes-Jewish Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Osteoclasts

Research focus

OsteoclastsBiological Signal TransductionPhosphorylationTyrosineCell DifferentiationColony Stimulating FactorTissue /Cell CultureMediatingMindLaboratory MouseOsteoporosisFibroblastsCellsProtein Structure FunctionCell TypeCell ProliferationHigh Performance Liquid ChromatographyDisease /Disorder Prevention /ControlDrug Adverse EffectAnimaliaCathepsin KAntiaids AgentBone ResorptionComputer Retrieval Of Information On Scientific Projects Database

Grant awards (19)

PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$8,730
P41 · FY2009 · RR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$258,751
R01 · FY2008 · AR · contact PI
M-CSF SIGNALLING IN OSTEOCLAST FORMATION AND FUNCTION$5,991
P41 · FY2008 · RR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$1,285
P41 · FY2008 · RR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$264,031
R01 · FY2007 · AR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$162,351
R21 · FY2007 · AR · contact PI
Bone Loss and Its Prevention in HIV Patients$323,087
R01 · FY2006 · AR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$271,916
R01 · FY2006 · AR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$201,300
R21 · FY2006 · AR · contact PI
Bone Loss and Its Prevention in HIV Patients$330,863
R01 · FY2005 · AR
M-CSF Signaling in Osteoclast Formation and Function$278,460
R01 · FY2005 · AR
Bone Loss and Its Prevention in HIV Patients$351,325
R01 · FY2004 · AR
M-CSF Signaling in Osteoclast Formation and Function$278,460
R01 · FY2004 · AR
Bone Loss and Its Prevention in HIV Patients$351,325
R01 · FY2003 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$222,615
R01 · FY2003 · AR
Bone Loss and Its Prevention in HIV Patients$347,370
R01 · FY2002 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$202,461
R01 · FY2002 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$215,340
R01 · FY2001 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$211,349
R01 · FY2000 · AR